Recro Pharma Offers Poster Presentation Ahead of American Pain Society Meeting, Highlights 'Clinical Performance of IV Meloxicam 30mg, Including Statistically Significant Differences in SPID48 and Numerous Other Rescue Use and Pain Relief Metrics'